Motor Neurone Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are aged 18 or older, either male or female
- You have been diagnosed with Amyotrophic Lateral Sclerosis (ALS, also known as Motor Neurone Disease)
- You are experiencing, or beginning to experience, problems related to speaking, excessive saliva, or difficulty swallowing, as identified by your care team
- You have either never used an INEX therapy device but have been prescribed one, or you are already using one (confirm with trial site)
- You are currently being cared for by the ALS mobile team at either the Groupe Hospitalier du Havre or the CHU of Dijon in France
- Your healthcare team has determined that how quickly your condition is progressing is suitable for joining this study
- You are willing to take part in the research after being fully informed about it
- You are covered by French social security or an equivalent scheme
Who may not be able to join:
- You currently have an active infection, or you had a respiratory infection less than one month ago
- You have a mental health condition that would interfere with using the device correctly
- You have a history of laryngospasm (sudden, involuntary throat muscle spasms that briefly block breathing)
- You are unable to attend in-person appointments with the ALS team at either of the named hospitals
- You are pregnant
- You are currently under a legal protection order, such as guardianship or curatorship, or are deprived of liberty by a legal or administrative decision
- You meet any reason for not being included that appears after joining the study (confirm with trial site)
- You choose to withdraw your participation after joining
- You have passed away from any cause (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +332 32 73 32 32
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The average difference in PEF (Peak Expiratory Flow) in L/min with the use of the PEP function and without the use of this function.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.